Muscarinic‐3‐receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial-Reference-Cited by-同舟云学术

Muscarinic‐3‐receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial

Published:2022-04-14 Issue:5 Volume:41 Page:1139-1148
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

van Till Jan Willem Olivier¹^ORCID,Arita Eri¹,Kuroishi Kentaro¹,Croy Richard¹,Oelke Matthias²,van Koeveringe Gommert A.³,Chapple Christopher R.⁴,Yamaguchi Osamu⁵,Abrams Paul⁶^ORCID

Affiliation:

1. Medical and Development Astellas Pharma Inc. Cambridge Massachusetts USA

2. Department of Urology, Paediatric Urology and Uro‐Oncology St. Antonius Hospital Gronau Germany

3. Department of Urology Maastricht University Medical Center Maastricht The Netherlands

4. Department of Urology The Royal Hallamshire Hospital Sheffield UK

5. Department of Urology Fukushima Medical University Fukushima Japan

6. Bristol Urological Institute, North Bristol NHS Trust, Southmead Hospital Bristol UK

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.24931

Reference25 articles.

1. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB)

2. The Relation between Postvoid Residual and Occurrence of Urinary Tract Infection after Stroke in Rehabilitation Unit

3. The many faces of impaired bladder emptying

4. Functional consequences of chronic bladder ischemia

5. Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Muscarinic M₃ Receptor‐Positive Allosteric Modulator ASP8302 Following Single and Multiple Ascending Oral Doses in Healthy Volunteers;Clinical Pharmacology in Drug Development;2024-08-09

2. Muscarinic control of cardiovascular function in humans: a review of current clinical evidence;Clinical Autonomic Research;2024-02

3. Could a better understanding of the underlying pathophysiologies lead to more informed treatment choices in patients with lower urinary tract dysfunction due to an acontractile or underactive detrusor? ICI‐RS 2023;Neurourology and Urodynamics;2023-11-13

4. Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives;International Journal of Molecular Sciences;2023-10-24

5. Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials;Signal Transduction and Targeted Therapy;2023-09-06